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A B S T R A C T
Genital herpes is increasingly caused by herpes simplex virus type 1 (HSV-1), but recurrences are less
frequent than with HSV-2. Distinguishing between primary genital infection and reactivation can be
difﬁcult, but HSV-1 more often causes severe primary infections and fewer recurrences. However, as virus
reactivation is common during septic shock, a severe form of HSV-1 reactivation can occur in locations
other than the lungs, which remain the most common site. The case of a 79-year-old Caucasian man who
presented with HSV-1 epididymo-orchitis after three episodes of severe sepsis or septic shock in the
context of acute biliary necrotizing pancreatitis is described. This is the ﬁrst reported case of HSV-
1 epididymo-orchitis due to virus reactivation during sepsis.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Genital herpes is the most prevalent sexually transmitted
disease in the United States [1]. The prevalence of sexually
acquired herpes simplex virus type 1 (HSV-1) is underestimated,
with an increased incidence of HSV-1 genital infection in the past
two decades [2]. Genital HSV-1 almost always causes a true
primary severe infection, but with fewer recurrences and less
asymptomatic carriage [3]. However, HSV-1 reactivation is
common during septic shock, and HSV is a common pathogen in
immunocompetent individuals that persists in the host after
primary infection. We present herein the ﬁrst reported case of
HSV-1 epididymo-orchitis due to virus reactivation during severe
sepsis. This case highlights the fact that HSV reactivation does not
solely occur in the lungs during severe sepsis. The importance of
early diagnosis and treatment of severe viral infection is discussed.Abbreviations: ICU, intensive care unit; CT, computed tomography; WOPN,
walled-off pancreatic necrosis; PCR, polymerase chain reaction; ELISA, enzyme
linked immunosorbent assay; SOFA, sepsis-related organ failure assessment score.
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Herein, we report a case of epididymo-orchitis as a severe form
of HSV type 1 genital recurrence. A 79-year-old patient was
admitted to the ICU with severe biliary acute necrotizing
pancreatitis that developed in the month prior to admission. He
presented with many septic and abdominal complications. First,
endoscopic transluminal drainage was performed because of a
retrogastric abscess. One week later, he developed a new episode of
severe sepsis with spontaneous bacterial peritonitis and late-onset
ventilator-associated pneumonia, with Escherichia coli and Proteus
spp. isolated from bacterial cultures of both sites. The patient
received appropriate antibiotic therapy with amoxicillin/clavu-
lanic acid, with a good therapeutic response. After three weeks, he
again developed a new episode of severe sepsis. CT-guided
drainage was performed twice for two new peripancreatic
collections. Despite antibiotic therapy with cefepime and oﬂox-
acin, septic shock developed again, and was rapidly complicated by
multiple organ failure with an abdominal compartment syndrome
and acute respiratory distress syndrome. Septic shock was caused
by ampicillin-susceptible Enterococcus faecalis, secondary to ileus
with bacterial translocation. The patient’s condition improved
rapidly after initiation of empirical broad-spectrum antimicrobial
therapy. He underwent percutaneous CT-guided drainage of a new
subcapsular left liver abscess on day 5. Moreover, because a largeder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Hydrocele of the right epididymis and increase in vascularization on color
doppler imaging.
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for internal drainage with concomitant debridement of WOPN on
day 7. Independent of the abdominal complications, the clinical
course was marked by an episode of HSV-1 epididymo-orchitis on
day 10. Clinically, the patient ﬁrst presented with an enlarged
scrotum. Two days later, groups of painful vesicles appeared
(Fig. 1).
Sonography identiﬁed a hydrocele, cutaneous swelling, and
diffuse hypoechoic heterogeneous enlargement of the right
epididymis without any abscess. Color Doppler imaging revealed
hyperemia, which suggested inﬂammation (Fig. 2).
HSV-1 polymerase chain reaction (PCR) of scrotal swabs was
positive on day 10, in association with a viral blood load of
1100 copies/ml. Bacterial and fungal cultures of scrotal cutaneous
swabs, urethral smears, and a single catheter urine specimen were
negative. Cytological diagnosis was positive with detection of
typical cytopathic effects of HSV-1 (syncytial multinucleated giant
cells) in scrapings from genital vesicles using Papanicolaou
staining. No speciﬁc serologic tests were performed. As soon as
the diagnosis was conﬁrmed by the urologist, intravenous
acyclovir treatment was initiated because of the clinical severity,
and was continued for ten days. Complete healing took two weeks,
but HSV-1 viral load was negative after only three days, and the
vesicles were transformed into ulcerations. After four more
transgastric necrosectomies of walled-off pancreatic necrosis
and CT-guided percutaneous transhepatic gallbladder drainage
for acute cholecystitis on day 23, the patient was ﬁnally discharged
from the ICU on day 43.
Other similar cases and comparative cases in the literature
Most genital HSV-1 infections are primary infections rather
than recurrences. Even though most primary infections are severe,
no case of epididymo-orchitis has been described. In men, HSV
presents most often as multiple grouped vesicles, painful erosions,
and ulcers that occur mainly on the prepuce and subpreputial areas
[4]. Our patient presented with a typical form of epididymo-
orchitis, conﬁrmed by sonography and typical HSV-1 cutaneous
vesicles and erosions. HSV reactivation – especially HSV-1 – is
common during septic shock, but our patient presented no risk
factor for a primary genital infection after one month in the ICU.
Many possible confounders exist during sepsis but the hypothesis
of a bacterial pathogen was excluded. Data from the literature are
lacking about HSV-1 reactivation, but a few cases of true infections
other than pneumonia due to HSV reactivation, such as hepatitis
[5,6] or extensive perinephric abscess [7], have been described.
Therefore, we conclude that this is the ﬁrst reported case of
epididymo-orchitis due to HSV-1 reactivation in a relatively
immunocompromised ICU patient in septic shock.Fig. 1. Enlarged scrotum associated withDiscussion
This patient developed HSV-1 epididymo-orchitis as a severe
form of genital HSV infection. Even though genital HSV-1 infection
is often severe, we found no case report of epididymo-orchitis
linked to HSV. In this patient, the diagnosis was not based solely on
clinical elements. Sonography, a polymerase chain reaction (PCR),
and a viral culture of scrotal swabs were positive for HSV-1.
Epididymo-orchitis is most often a sexually transmitted disease in
young men caused by Chlamydia trachomatis or Neisseria gonor-
rhoeae, and can also be caused by Enterobacteriaceae after a
complicated urinary tract infection. A few cases of tuberculous
epididymo-orchitis after BCG therapy for bladder cancer have also
been described, but no cases have yet been linked to a virus [8].
Sonography is currently the best imaging technique for the study of
scrotal contents, and conﬁrmed the diagnosis of epididymo-
orchitis [9]. Various echographic patterns have been described for
epididymitis including diffuse hypoechoic, nodular hypoechoic,
heterogeneous enlargement, or other typical ﬁndings including
hydrocele, cutaneous swelling, or abscess in the most severe case.
This patient presented four of these ﬁndings, making the diagnosis
certain (Fig. 2).
During both genital HSV-1 and HSV-2 infections, groups of
vesicles or ulcers develop in a single anatomical site and disappear
within 10 days. groups of vesicles on both testicles.
28 M. Fromentin et al. / IDCases 6 (2016) 26–28Usually, HSV-1 infection is deﬁned as the isolation of HSV-
1 from cultures of the genital tract [10], and the laboratory
conﬁrmation of infection and typing of HSV is essential for the
prognosis [4].
The diagnosis of HSV-1 epididymo-orchitis was certain but it
was difﬁcult to determine whether this patient had a primary
infection or reactivation.
No risk factors for primary HSV-1 infection, especially no recent
oral sex, were identiﬁed. Our patient developed symptoms after
one month in the ICU, and we presumed he had a recurrence.
Usually, HSV-1 primary infection is deﬁned as the isolation of HSV-
1 from cultures of the genital tract or seroconversion to HSV-1 in an
originally seronegative patient [10]. Accuracy of serological assays
was limited in the past by the extensive cross-reactivity between
antibodies to HSV-1 and HSV-2, but sensitive serological tests such
as ELISA can be helpful to diagnose seroconversion and to
differentiate an initial from a recurrent infection [11]. No speciﬁc
serologic tests were performed on this patient because there was
no likely impact on his treatment. We assume that this unusually
severe recurrence is explained by relative immunosuppression
induced by multiple preceding episodes of severe bacterial sepsis.
A recent study revealed that patients with prolonged sepsis had
reactivation of two or more latent viruses, especially cytomegalo-
virus (CMV), Epstein-Barr virus (EBV), and HSV. In this study nearly
half the blood samples for HSV converted from negative to positive
on day 7 after sepsis onset, and HSV viremia was associated with
higher SOFA scores [12]. Here, conditions were compatible with
HSV-1 reactivation in the genital tract.
This reactivation could have been from viremia or from travel
down a sensory nerve. During primary infection, HSV infects
genital epithelial cells, and then travels via sensory nerves to the
sacral root ganglion, where lifelong latency is established.
Intermittent reactivation of HSV from the sacral ganglia and lytic
replication of virus in the epithelium is thought to result in viral
shedding at the genital mucosa, and recurrences are thought to
occur predominantly at the site of primary acquisition. The
scrotum, testicle, and epididymis are innervated anteriorly by the
ilioinguinal, iliohypogastric, and genitofemoral nerves, which
originate from the lumbar plexus. Only the posterior portion of
the scrotum is innervated by the perineal branches of the pudendal
sensory and motor nerve, which originates from the S2, S3, and
S4 ganglia of the sacral plexus. Moreover, reactivation from travel
down a sensory nerve did not seem to be the most likely
hypothesis. However, a recent study reported that HSV-2 genital
reactivation in women is often multifocal and occurs in a wide
anatomic distribution in the genital tract. This reveals that
reactivation from the ganglia that form the pudendal nerve could
result in the potential appearance of HSV throughout the branches
of the nerve [13]. However, the outbreak was limited to one nerve
and the sacral plexus, and in our case did not explain reactivation
from the ganglia that form the lumbar plexus.
In addition, the reactivation was probably related to viremia, as
most cases of viral orchitis are caused by hematogenous spread.
The most typical example is orchitis developing in association with
mumps [14].
For the treatment of recurrent HSV infection, European
guidelines for the management of genital herpes recommended
episodic antiviral therapy with acyclovir 400 mg three times a day
for ﬁve days, starting early in an outbreak [15]. We decided to treat
our patient for ten days because we assumed he was severely
immunocompromised, but the clinical course was favorable, with
HSV-1 sampling negative for viremia within only three days.Conclusion
This is the ﬁrst reported case of epididymo-orchitis linked to
HSV-1 recurrence after several severe episodes of sepsis.
Reactivation of latent viruses is common in prolonged sepsis,
with frequencies similar to those occurring in patients in an
immunosuppressed state. However, this unusual presentation of
HSV-1 reactivation is evidence of clinically-relevant immunosup-
pression due to severe sepsis. This case highlights the importance
of diagnosing viral infection, because we do not know whether
reactivated latent viruses may contribute to morbidity and
mortality in sepsis.
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